Fig. 1From: Cardiorenal protection with dapagliflozin in patients with type 2 diabetes mellitus and chronic coronary syndrome undergoing percutaneous coronary intervention: a registry cross-sectional studyFlow diagram of study population enrollmentBack to article page
Cardiovascular Diabetology